Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1342

1.

Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.

Luo BH, Xiong F, Wang JP, Li JH, Zhong M, Liu QL, Luo GQ, Yang XJ, Xiao N, Xie B, Xiao H, Liu RJ, Dong CS, Wang KS, Wen JF.

PLoS One. 2014 Jun 19;9(6):e99922. doi: 10.1371/journal.pone.0099922. eCollection 2014.

2.

Aquaporin 3 promotes epithelial-mesenchymal transition in gastric cancer.

Chen J, Wang T, Zhou YC, Gao F, Zhang ZH, Xu H, Wang SL, Shen LZ.

J Exp Clin Cancer Res. 2014 May 3;33:38. doi: 10.1186/1756-9966-33-38.

3.

Epithelial mesenchymal transition is required for acquisition of anoikis resistance and metastatic potential in adenoid cystic carcinoma.

Jia J, Zhang W, Liu JY, Chen G, Liu H, Zhong HY, Liu B, Cai Y, Zhang JL, Zhao YF.

PLoS One. 2012;7(12):e51549. doi: 10.1371/journal.pone.0051549. Epub 2012 Dec 14. Retraction in: PLoS One. 2014;9(9):e108117.

4.

Suppression of the Epidermal Growth Factor-like Domain 7 and Inhibition of Migration and Epithelial-Mesenchymal Transition in Human Pancreatic Cancer PANC-1 Cells.

Wang YL, Dong FL, Yang J, Li Z, Zhi QM, Zhao X, Yang Y, Li DC, Shen XC, Zhou J.

Asian Pac J Cancer Prev. 2015;16(9):4065-9.

5.

CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.

Zang M, Zhang B, Zhang Y, Li J, Su L, Zhu Z, Gu Q, Liu B, Yan M.

PLoS One. 2014 Nov 14;9(11):e112908. doi: 10.1371/journal.pone.0112908. eCollection 2014.

6.
7.

HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.

Xu J, Zhang X, Wang H, Ge S, Gao T, Song L, Wang X, Li H, Qin Y, Zhang Z.

Biomed Pharmacother. 2017 Apr;88:421-429. doi: 10.1016/j.biopha.2017.01.013. Epub 2017 Jan 22.

PMID:
28122307
8.

ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3K/AKT signaling pathway.

Wei S, Wang L, Zhang L, Li B, Li Z, Zhang Q, Wang J, Chen L, Sun G, Li Q, Xu H, Zhang D, Xu Z.

Tumour Biol. 2016 Sep;37(9):12813-12821. Epub 2016 Jul 23.

PMID:
27449034
9.

Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells.

Li H, Xu L, Li C, Zhao L, Ma Y, Zheng H, Li Z, Zhang Y, Wang R, Liu Y, Qu X.

Mol Cancer. 2014 Jun 2;13:136. doi: 10.1186/1476-4598-13-136.

10.

C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.

Wang L, Yin J, Wang X, Shao M, Duan F, Wu W, Peng P, Jin J, Tang Y, Ruan Y, Sun Y, Gu J.

Gastroenterology. 2016 May;150(5):1183-1195.e16. doi: 10.1053/j.gastro.2016.01.034. Epub 2016 Feb 6.

PMID:
26855187
11.

MAWBP and MAWD inhibit proliferation and invasion in gastric cancer.

Li DM, Zhang J, Li WM, Cui JT, Pan YM, Liu SQ, Xing R, Lu YY.

World J Gastroenterol. 2013 May 14;19(18):2781-92. doi: 10.3748/wjg.v19.i18.2781.

12.

The P2RY2 Receptor Induces Carcinoma Cell Migration and EMT Through Cross-Talk With Epidermal Growth Factor Receptor.

Martínez-Ramírez AS, Garay E, García-Carrancá A, Vázquez-Cuevas FG.

J Cell Biochem. 2016 Apr;117(4):1016-26. doi: 10.1002/jcb.25390. Epub 2015 Oct 14.

PMID:
26443721
13.

BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.

Kang MH, Kim JS, Seo JE, Oh SC, Yoo YA.

Exp Cell Res. 2010 Jan 1;316(1):24-37. doi: 10.1016/j.yexcr.2009.10.010. Epub 2009 Oct 14.

PMID:
19835871
14.

DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.

Wang YG, Xu L, Jia RR, Wu Q, Wang T, Wei J, Ma JL, Shi M, Li ZS.

Dig Dis Sci. 2016 Aug;61(8):2272-83. doi: 10.1007/s10620-016-4116-3. Epub 2016 Mar 24.

PMID:
27010547
15.

PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.

Zhang H, Sun JD, Yan LJ, Zhao XP.

Biochem Biophys Res Commun. 2016 Sep 16;478(2):845-51. doi: 10.1016/j.bbrc.2016.08.035. Epub 2016 Aug 6.

PMID:
27507215
16.

Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway.

Maseki S, Ijichi K, Tanaka H, Fujii M, Hasegawa Y, Ogawa T, Murakami S, Kondo E, Nakanishi H.

Br J Cancer. 2012 Mar 13;106(6):1196-204. doi: 10.1038/bjc.2012.24. Epub 2012 Feb 7.

17.

CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.

Tang J, Xiao L, Cui R, Li D, Zheng X, Zhu L, Sun H, Pan Y, Du Y, Yu X.

Oncol Rep. 2016 Feb;35(2):1153-62. doi: 10.3892/or.2015.4470. Epub 2015 Dec 2.

PMID:
26718770
18.

CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.

Liang W, Hao Z, Han JL, Zhu DJ, Jin ZF, Xie WL.

Urol Oncol. 2014 Aug;32(6):855-63. doi: 10.1016/j.urolonc.2014.01.005. Epub 2014 Jun 23.

PMID:
24968949
19.

Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.

Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L, Jiang H, Ren J, Cai J, Li Q.

BMC Cancer. 2015 Mar 5;15:97. doi: 10.1186/s12885-015-1119-y.

20.

MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer.

Zhou X, Hu Y, Dai L, Wang Y, Zhou J, Wang W, Di W, Qiu L.

PLoS One. 2014 May 9;9(5):e96718. doi: 10.1371/journal.pone.0096718. eCollection 2014.

Supplemental Content

Support Center